Germany Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Germany Cardiovascular Devices Market Report Segments the Industry Into by Device Type (Diagnostic and Monitoring Devices [Electrocardiogram (ECG), Remote Cardiac Monitoring, Other Diagnostic and Monitoring Devices], Therapeutic and Surgical Devices [Cardiac Assist Devices, Cardiac Rhythm Management Device, Catheter, Grafts, Heart Valves, Stents, Other Therapeutic and Surgical Devices]).

Germany Cardiovascular Devices Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
View Global Report

Compare market size and growth of Germany Cardiovascular Devices Market with other markets in Healthcare Industry

Germany Cardiovascular Devices Market Analysis by Mordor Intelligence

The Germany cardiovascular devices market size is USD 3.76 billion in 2024 and is forecast to expand at a 7.39% CAGR to reach USD 5.81 billion by 2030. Higher procedure volumes, an aging population, and expanding remote-monitoring mandates anchor long-term demand. Hospitals continue to invest in structural-heart and rhythm-management systems as DRG payments favor catheter-based interventions over conservative therapy. At the same time, mandatory telemonitoring of chronic heart-failure patients generates recurring revenue for implantable loop recorders and cloud analytics, turning the Germany cardiovascular devices market into a data-driven services arena. EU-MDR compliance costs eliminate many low-margin SKUs, shifting innovation toward AI-enabled diagnostics, minimally invasive systems, and fully implantable pumps that shorten inpatient stays. Although pharmacological advances temper device uptake in early-stage disease, Germany’s super-aged demographic keeps replacement and upgrade cycles brisk, sustaining a predictable mid-single-digit revenue trajectory through 2030.

Key Report Takeaways

By device type, Therapeutic and Surgical Devices held 69.20% of the Germany cardiovascular devices market share in 2024; Diagnostic and Monitoring Devices are set to post the highest 6.33% CAGR through 2030.  

By application, Coronary Artery Disease represented 43.21% of revenue in 2024, while Heart Failure is projected to advance at 6.84% CAGR between 2025-2030.  

By end-user, hospitals accounted for 70.20% of spending in 2024; the “Other” segment (ambulatory centers, cardiac clinics, home care) is poised for a 7.11% CAGR to 2030.  

Segment Analysis

Therapeutic and Surgical Devices captured 69.20% Germany cardiovascular devices market share in 2024, boosted by 164 TAVI cases per million residents. Growing reliance on drug-eluting stents, left-atrial appendage occluders, and VADs underscores hospitals’ preference for minimally invasive solutions that shorten intensive-care occupancy. Despite the maturity of percutaneous coronary intervention, high-risk subsets such as calcified lesions sustain demand for lithotripsy catheters reimbursed under new OPS codes.  

Diagnostic and Monitoring Devices, although smaller, will expand at 6.33% CAGR to 2030, buoyed by AI-driven ECG analytics and mandatory heart-failure telemonitoring.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

By Application: Coronary Stability, Heart-Failure Upsurge

Coronary Artery Disease maintains the largest revenue pool at 43.21% in 2024, sustained by high prevalence among workers retiring after 2025. Hospitals increasingly pair fractional flow reserve wires with balloon-expandable stents from Andramed or Bentley InnoMed to optimize lesion management.

By End-User: Hospital Core, Outpatient Surge

Hospitals delivered 70.20% of 2024 sales, led by university centers that act as reference sites for first-in-human trials. Hybrid-DRG flat fees enacted in 2024 stabilize revenue forecasts, encouraging capital budgeting for integrated cath-lab-operating-room hybrids [1]Source: GKV-Spitzenverband, “Hybrid-DRG,” gkv-spitzenverband.de .  

The “Other” segment grows fastest at 7.11% CAGR, as ambulatory surgical centers adopt same-day PCI and home-care services deploy wearable ECG patches. Statutory reimbursement for DiGA apps widens access to mobile arrhythmia detection, embedding the Germany cardiovascular devices market into everyday life.

Germany Cardiovascular Devices Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Geography Analysis

Southern states such as Bavaria and Baden-Württemberg host dense medical-technology clusters around Munich and Stuttgart. Proximity to Fraunhofer institutes and Technical University campuses accelerates prototype iteration, helping regional firms file MDR submissions sooner. These states also generate 34% of national cath-lab procedures, partly because affluent populations seek early elective interventions.

North-Rhine-Westphalia concentrates the highest structural-heart case volume—Cologne, Düsseldorf, and Essen collectively performed over 12,000 TAVI procedures in 2024. Large tertiary hospitals leverage diversified funding streams that combine DRG, teaching grants, and EU research budgets to outfit hybrid theaters. Device vendors treat these centers as launchpads, because published real-world evidence from Rhine-Ruhr regions influences guideline committees.

Eastern regions such as Saxony rely on telecardiology to offset longer travel times to university hospitals. Broadband penetration exceeding 95% enables continuous data uploads from rural heart-failure patients, supporting service contracts between device manufacturers and regional telehealth call centers. Funding from the European Regional Development Fund further subsidizes server infrastructure, positioning the East as a service hub that exports telemetry analytics nationwide.

Competitive Landscape

Germany cardiovascular devices industry competition is moderate, with domestic innovators coexisting alongside global majors. BIOTRONIK’s DX platform integrates atrial sensing into single-chamber ICDs, reducing lead count and complication risk. The firm’s Berlin headquarters houses vertical production lines, ensuring supply resilience during MDR-related shortages.

Berlin Heals and Protembis exemplify venture-backed niche specialists. Berlin Heals’ C-MIC device applies bioelectric stimulation to heart-failure ventricles, aiming to avoid life-long pharmacotherapy. Protembis’ ProtEmbo filter addresses cerebral embolic risk during TAVI, aligning with hospitals’ shift toward patient-safety metrics. Both companies leverage German Angel Investors’ tax credits and Fraunhofer project grants to co-fund pivotal trials.

AI-centric disruptors such as LARALAB partner with imaging vendors to embed eligibility algorithms directly into hospital PACS, compressing CT-review time from hours to minutes[2]Source: Edward Plugge, “LARALAB launches REC,” einpresswire.com . Large multinationals increasingly license these algorithms rather than build in-house, intensifying M&A as buyers chase software intellectual property that fortifies their hardware install base.

Germany Cardiovascular Devices Industry Leaders

  1. Abbott Laboratories

  2. Boston Scientific Corporation

  3. Medtronic PLC

  4. Edwards Lifesciences

  5. Cardinal Health Inc

  6. *Disclaimer: Major Players sorted in no particular order
Picture2.png
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • May 2024: LARALAB launched ‘REC—Rapid Eligibility Check,’ enabling AI-based screening for mitral and tricuspid interventions
  • August 2024: Heidelberg University Hospital implanted two Carmat Aeson total artificial hearts, extending support for transplant-eligible patients

Table of Contents for Germany Cardiovascular Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Expansion of Reimbursed TAVI & TMVR Procedures Boosting Transcatheter Heart Valve Demand
    • 4.2.2 Mandatory Remote Heart-Failure Telemonitoring (G-BA 2022) Accelerating Implantable Loop Recorder Uptake
    • 4.2.3 Germany’s Highest PCI per-Capita in EU Sustaining DES & Guidewire Replacement Cycles
    • 4.2.4 Super-Aged Demographics in Southern & Eastern States Driving Pacemaker & VAD Implant Volumes
    • 4.2.5 R&D Tax Incentives & MDR Transition Supporting Domestic Innovators (e.g., BIOTRONIK)
    • 4.2.6 Krankenhaus-Zukunft Act Funding Digital ICU / OR Hemodynamic Monitoring Systems
  • 4.3 Market Restraints
    • 4.3.1 EU-MDR Post-Market Costs Forcing SMEs to Withdraw Legacy Cardiovascular SKUs
    • 4.3.2 DRG Budget Caps Curbing Ventricular Assist Device Implant Adoption Beyond University Centers
    • 4.3.3 Value-Based Procurement Driving Price Erosion in Stents & Balloons
    • 4.3.4 Pharmacotherapy Advances (e.g., SGLT2i) Moderating Device Therapy Volumes
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 Diagnostic & Monitoring Devices
    • 5.1.1 ECG Systems
    • 5.1.2 Remote Cardiac Monitor
    • 5.1.3 Cardiac MRI
    • 5.1.4 Cardiac CT
    • 5.1.5 Echocardiography / Ultrasound
    • 5.1.6 Fractional Flow Reserve (FFR) Systems
  • 5.2 Therapeutic & Surgical Devices
    • 5.2.1 Coronary Stents
    • 5.2.1.1 Drug-Eluting Stents
    • 5.2.1.2 Bare-Metal Stents
    • 5.2.1.3 Bioresorbable Stents
    • 5.2.2 Catheters
    • 5.2.2.1 PTCA Balloon Catheters
    • 5.2.2.2 IVUS/OCT Catheters
    • 5.2.3 Cardiac Rhythm Management
    • 5.2.3.1 Pacemakers
    • 5.2.3.2 Implantable Cardioverter Defibrillators
    • 5.2.3.3 Cardiac Resynchronization Therapy Devices
    • 5.2.4 Heart Valves
    • 5.2.4.1 TAVR/TAVI
    • 5.2.4.2 Mechanical Valves
    • 5.2.4.3 Tissue/Bioprosthetic Valves
    • 5.2.5 Ventricular Assist Devices
    • 5.2.6 Artificial Hearts
    • 5.2.7 Grafts & Patches
    • 5.2.8 Other Cardiovascular Surgical Devices
  • 5.3 By Application
    • 5.3.1 Coronary Artery Disease
    • 5.3.2 Arrhythmia
    • 5.3.3 Heart Failure
    • 5.3.4 Structural Heart Disease
    • 5.3.5 Hypertension
    • 5.3.6 Others
  • 5.4 By End user
    • 5.4.1 Hospitals
    • 5.4.2 Home-Care Settings
    • 5.4.3 Others

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
    • 6.3.1 Medtronic plc
    • 6.3.2 Abbott Laboratories
    • 6.3.3 Boston Scientific Corporation
    • 6.3.4 BIOTRONIK SE & Co. KG
    • 6.3.5 B. Braun Melsungen AG
    • 6.3.6 Edwards Lifesciences Corp.
    • 6.3.7 Siemens Healthineers AG
    • 6.3.8 GE HealthCare Technologies Inc.
    • 6.3.9 Philips Healthcare
    • 6.3.10 Terumo Corp.
    • 6.3.11 LivaNova PLC
    • 6.3.12 Getinge AB (Maquet Cardiopulmonary)
    • 6.3.13 Zoll Medical Corp.
    • 6.3.14 Schiller AG
    • 6.3.15 Drägerwerk AG & Co. KGaA
    • 6.3.16 Straub Medical AG
    • 6.3.17 Lepu Medical Technology
    • 6.3.18 CardioFocus Inc.
    • 6.3.19 MicroPort Scientific Corp.
    • 6.3.20 W. L. Gore & Associates Inc.

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment

8. G. Regional Growth Rates (Not Applicable)

9. Final TOC does not include continent-level geographic segmentation; hence no regional growth-rate table is required under guideline G.

10. .......

11. New Research

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Germany Cardiovascular Devices Market Report Scope

As per the scope of the report, cardiovascular devices are used to diagnose and treat heart disease and related cardiovascular problems. Cardiac Devices offers monitoring services to hospitals and physicians to take care of the patients with the help of the data collected by cardiac monitors. The German Cardiovascular Devices Market is segmented by Device type, Diagnostic and Monitoring Devices (Electrocardiogram, Remote Cardiac Monitoring, and Other Diagnostic and Monitoring Devices), and Therapeutic and Surgical Devices (Cardiac Assist Devices, Cardiac Rhythm Management Device, Catheter, Grafts, Heart Valves, Stents, and Other Therapeutic and Surgical Devices). The report offers the value (in USD million) for the above segments.

Diagnostic & Monitoring Devices ECG Systems
Remote Cardiac Monitor
Cardiac MRI
Cardiac CT
Echocardiography / Ultrasound
Fractional Flow Reserve (FFR) Systems
Therapeutic & Surgical Devices Coronary Stents Drug-Eluting Stents
Bare-Metal Stents
Bioresorbable Stents
Catheters PTCA Balloon Catheters
IVUS/OCT Catheters
Cardiac Rhythm Management Pacemakers
Implantable Cardioverter Defibrillators
Cardiac Resynchronization Therapy Devices
Heart Valves TAVR/TAVI
Mechanical Valves
Tissue/Bioprosthetic Valves
Ventricular Assist Devices
Artificial Hearts
Grafts & Patches
Other Cardiovascular Surgical Devices
By Application Coronary Artery Disease
Arrhythmia
Heart Failure
Structural Heart Disease
Hypertension
Others
By End user Hospitals
Home-Care Settings
Others
Diagnostic & Monitoring Devices
ECG Systems
Remote Cardiac Monitor
Cardiac MRI
Cardiac CT
Echocardiography / Ultrasound
Fractional Flow Reserve (FFR) Systems
Therapeutic & Surgical Devices
Coronary Stents Drug-Eluting Stents
Bare-Metal Stents
Bioresorbable Stents
Catheters PTCA Balloon Catheters
IVUS/OCT Catheters
Cardiac Rhythm Management Pacemakers
Implantable Cardioverter Defibrillators
Cardiac Resynchronization Therapy Devices
Heart Valves TAVR/TAVI
Mechanical Valves
Tissue/Bioprosthetic Valves
Ventricular Assist Devices
Artificial Hearts
Grafts & Patches
Other Cardiovascular Surgical Devices
By Application
Coronary Artery Disease
Arrhythmia
Heart Failure
Structural Heart Disease
Hypertension
Others
By End user
Hospitals
Home-Care Settings
Others
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

1. How big is the Germany cardiovascular devices market in 2025?

The market stands at USD 4.03 billion.

2. What growth rate is projected for the Germany cardiovascular devices market through 2030?

A 7.39% CAGR is forecast from 2025-2030.

3. Which segment grows fastest within the Germany cardiovascular devices market?

Diagnostic and Monitoring Devices will rise at 6.33% CAGR during the forecast period.

4. Why is mandatory telemonitoring significant for German heart-failure care?

Statutory reimbursement requires remote monitoring for over 3 million patients, driving higher implantable recorder adoption and reducing readmissions.

Page last updated on: July 14, 2025

Germany Cardiovascular Devices Market Report Snapshots